相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis
Boqiang Zhao et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
I Hartlapp et al.
ESMO OPEN (2022)
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer
Silvia Molinelli et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer
Masahiko Okamoto et al.
CANCERS (2021)
A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
Masaru Fukahori et al.
MEDICINE (2021)
Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomograms
Lilly J. H. Brada et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy
Yasuhito Hagiwara et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan
Ippei Matsumoto et al.
PANCREATOLOGY (2019)
Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas
Shohei Kawashiro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
Yoko Goto et al.
RADIATION ONCOLOGY (2018)
Carbon-ion radiotherapy for locoregional recurrence after primary surgery for pancreatic cancer
Shohei Kawashiro et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost- intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
Eun Sang Oh et al.
RADIATION ONCOLOGY JOURNAL (2018)
Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
Makoto Shinoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial
Pascal Hammel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan
Taku Inaniwa et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Combined radiochemotherapy in patients with locally advanced pancreatic cancer: A meta-analysis
Yue Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Effects of Carbon Ion Beam on Putative Colon Cancer Stem Cells and Its Comparison with X-rays
Xing Cui et al.
CANCER RESEARCH (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia
T Nakano et al.
CLINICAL CANCER RESEARCH (2006)
CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials
NR Maisey et al.
BRITISH JOURNAL OF CANCER (2005)